BioSpace News Archive

Getinge’s Board of Directors Proposes a Distribution of the Patient Post-Acute Care Business Area to Getinge’s Shareholders

The proposal includes the distribution of all shares in Arjo, where each share of series A in Getinge entitles to one share of series A in Arjo and each share of series B in Getinge entitles to one share of series B in Arjo.

November 10, 2017

·

12 min read

Business

Medivir Appoints Christina Herder as Executive VP Strategic Business Development

Christina will report to CEO Christine Lind and will join Medivir’s executive management team.

November 10, 2017

·

2 min read

BioForest

Alpine Immune Sciences Presents Preclinical Data on Novel Immuno-Oncology Molecules at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting

The findings will be presented on Friday, November 10, in a poster session titled “Immune Modulation, Cytokines, and Antibodies” [#P343] at the Society for Immunotherapy of Cancer’s (SITC) 32nd Annual Meeting in National Harbor, MD.

November 10, 2017

·

5 min read

Drug Development

Results From Boehringer Ingelheim’s Six-Month Lung Imaging Study Showed Slowing of Fibrotic Progression in Patients With IPF Treated With Ofev Versus Placebo

The results are being presented at the PFF Summit 2017, November 9-11 in Nashville, Tenn.

November 10, 2017

·

7 min read

Pharm Country

Ethicon’s BIOPATCH Protective Disk With CHG Meets New CDC Recommendation and Continues as the Standard of Care to Reduce Intravascular Catheter-Related Blood Stream Infections

BIOPATCH is the only IV dressing proven in multiple meta-analyses and randomized controlled trials to reduce risk of central line associated bloodstream infections in patients with central and arterial lines.

November 10, 2017

·

4 min read

Business

Dynatronics Corp. Schedules Conference Call to Report Financial Results for First Fiscal Quarter

Dynatronics today announced that its financial results for the quarter ended September 30, 2017 will be released pre market open on Tuesday, November 14, 2017.

November 10, 2017

·

1 min read

Biotech Bay

Veeva Systems Release: Industry Research Shows 97% of Companies to Increase Use of Real-World Patient Data for More Accurate Decision-Making

November 10, 2017

·

6 min read

Drug Development

Blueprint Medicines Announces New Data From Ongoing Phase I Clinical Trial of BLU-285 in Patients With Advanced Gastrointestinal Stromal Tumors Showing Strengthened Clinical Activity Across Spectrum of KIT and Pdgfrα Genotypes

The data confirm and build upon data previously presented for BLU-285 in patients with advanced GIST, demonstrating robust clinical activity and a favorable safety profile.

November 10, 2017

·

15 min read

Business

IP Veteran Andrew Filler Joins BioSig Technologies’ Board of Directors

Mr. Filler brings to BioSig over 20 years of experience in intellectual property for technology and medical device companies.

November 10, 2017

·

4 min read

Notice of Extraordinary General Meeting in Getinge AB

The shareholders of Getinge are hereby invited to attend the EGM” to be held on Monday, December 4, 2017 at 16.00 CET, at Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden.

November 10, 2017

·

5 min read